Cancer Advances Supports PanCAN’s PurpleStride Raleigh-Durham 2021
The Pancreatic Cancer Action Network’s (PanCAN) PurpleStride is a year-round national movement that funds life-changing programs and services to accelerate progress for pancreatic cancer patients.
At nearly 60 PurpleStride events in communities nationwide, pancreatic cancer survivors, families, caregivers, researchers and supporters passionate about changing the future of pancreatic cancer come together to celebrate and honor everyone affected by the disease.
“PurpleStride is a fun, happy, energetic event. Pancreatic cancer is a difficult disease, so I love that PurpleStride brings together all the people who have been impacted. We have a shared bond. The sense of community I’ve gotten from PanCAN and PurpleStride is huge to me.” Anna Shen, caregiver
PurpleStride is the number-one way PanCAN raises money to fight pancreatic cancer in a comprehensive way through:
We fund critical research, including a nationally acclaimed grants program and revolutionary clinical initiatives. We also publish learnings and share with the scientific community to make progress more quickly for patients.
Our compassionate, highly trained case managers provide in-depth disease and treatment information, helping patients and families navigate their next steps after diagnosis — all free of charge.
When we all speak with a unified voice, Congress listens. That’s why we continue to take our urgent message about the need for more federal research funding for pancreatic cancer to Capitol Hill. It’s paying off – funding continues to climb.
- April 9, 2021 – Cancer Advances, Inc. Announces Minisymposium Presentation at AACR
- March 18, 2021 – Cancer Advances, Inc. Announces Abstract at AACR
- November 11, 2019 – Cancer Advances, Inc. announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases” in the American Journal of Physiology—Gastrointestinal and Liver Physiology
- November 11, 2019 – Cancer Advances, Inc. announces new publication: “Gastrin Vaccine Improves Response to Immune Checkpoint Antibody in Murine Pancreatic Cancer by Altering the Tumor Microenvironment”, in the journal Cancer Immunology, Immunotherapy